Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 1 No. 2, November 1992 TABLE OF CONTENTS
  •  Online Features
  Brief Reports
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Dermatologic Adverse Drug Reactions in a Family Medicine Setting

Timothy J. Ives, PharmD, MPH; Eleanor J. Bentz, MSPH; Robert E. Gwyther, MD

Arch Fam Med. 1992;1(2):241-245.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Arndt KA, Jick H. Rates of cutaneous reactions to drugs. JAMA. 1976;235:918-922. FREE FULL TEXT
2. Stewart RB, May FE, Cullen SI. Dermatologic adverse drug reactions in hospitalized patients. Am J Hosp Pharm. 1979;36:609-612. PUBMED
3. Kauppinen K, Stubb S. Drug eruptions: causative agents and clinical types. Acta Derm Venerol (Stockh). 1984;64:320-324.
4. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. JAMA. 1986;256:3358-3363. FREE FULL TEXT
5. Alanko K, Stubb S, Kauppinen K. Cutaneous drug reactions: clinical types and causative agents. Acta Derm Venereol (Stockh). 1989;69:223-226. PUBMED
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. PUBMED
7. Karch PE, Lasagna L. Adverse drug reactions: a critical review. JAMA. 1975; 234:1236-1241. FREE FULL TEXT
8. Seidl LG, Thornton GP, Cluff LE. Epidemiological studies of adverse drug reactions. Am J Public Health. 1965;55:1170-1175. FREE FULL TEXT
9. Daniel WW. Hypothesis testing. In: Biostatistics: A Foundation for Analysis in the Health Sciences. 3rd ed. New York, NY: John Wiley & Sons: 1983:192-194.
10. Kaplan MH, Sadick N, McNutt NS, Meltzer M, Sarngadharan MG, Pahwa S. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol. 1987;16:485-506. PUBMED
11. Kalow W. Ethnic differences in drug metabolism. Clin Pharmacokinet. 1982; 7:373-400. PUBMED
12. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HHP. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: a prospective study. J Chronic Dis. 1986;39:533-542. PUBMED
13. Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med. 1987;147:1117-1120. FREE FULL TEXT
14. Carter BL, Helling DK, Jones ME, Friedman RL, Ellsworth A. Multicenter study of family physician prescribing. J Fam Pract. 1984;19:497-501. PUBMED
15. Jackson MG, Drechsler-Martell CR, Jackson EA. Family practice residents' prescribing patterns. Drug Intell Clin Pharm. 1985;19:205-209. ABSTRACT
16. Koch H, Knapp DA. Highlights of drug utilization in office practice: National Ambulatory Care Medical Care Survey, 1985. Advance Data From Vital and Health Statistics, No. 134. Hyattsville, Md: US Public Health Service; 1987:1-12. Department of Health and Human Services publication (PHS) 87-1250.
17. Fisher S, Bryant SG. Postmarketing surveillance of adverse drug reactions: patient self-monitoring. J Am Board Fam Pract. 1992;5:17-25. PUBMED
18. Hutchinson TA, Lane DA. Standardized methods of causality assessment for suspected adverse drug reactions. J Chronic Dis. 1986;39:857-860. PUBMED
19. Rieder M, Uetrecht J, Shear N, Cannon M, Miller M, Spielberg S. Diagnosis of sulfonamide hypersensitivity reactions by in vitro 'rechallenge' with hydroxytamine metabolites. Ann Intern Med. 1989;110:286-289. PUBMED
20. Halevy S, Grunwald MH, Sandbank M, Buimovice B, Joshua H, Livni E. Macrophage migration inhibition factor (MIP) in drug eruption. Arch Dermatol. 1990; 126:48-51. FREE FULL TEXT
21. Faich GA, Knapp D, Dreis M, Turner W. National drug surveillance: 1985. JAMA. 1987;257:2068-2070. FREE FULL TEXT
22. Strom BL, Tugwell P. Pharmacoepidemiology: current status, prospects, and problems. Ann Intern Med. 1990;113:179-181. FREE FULL TEXT
23. Schneeweiss R, Cherkin DC, Hart GL. The effect of including secondary diagnoses on the description of the diagnostic content of family practice. Med Care. 1984;22:1058-1063. PUBMED
24. Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986;1:205-212.
25. Rogers AS, Israel E, Smith CR, et al. Physician knowledge, attitudes, and behavior related to adverse drug events. Arch Intern Med. 1988;148:1596-1600. FREE FULL TEXT